US proposals would require greater disclosure of clinical trial data

BMJ 2014;349:g7103
Author: Michael McCarthy
“Under two proposed rule changes the US government will expand the number of trials that must report clinical trial data. This would include trials of drugs, devices, or biological products regulated by the Food and Drug Administration (FDA), regardless of who funds or conducts them, and any trials funded by the US National Institutes of Health (NIH).1”
Find extract here.